Quarraisha Abdool Karim

Quarraisha Abdool Karim
Name	Quarraisha Abdool Karim
Birth date	1960s
Birth place	Durban, South Africa
Nationality	South African
Occupation	Epidemiologist, Professor
Known for	HIV research, public health leadership

Quarraisha Abdool Karim is a South African epidemiologist and infectious disease specialist known for her work on HIV prevention, particularly among adolescent girls and young women, and for shaping international public health responses to the HIV/AIDS pandemic. She has held leadership roles at academic institutions and global health organizations and has been influential in translating clinical research into policy and implementation across Africa and internationally. Her multidisciplinary collaborations span basic science, clinical trials, behavioral science, and health systems strengthening.

Early life and education

Born in Durban, Abdool Karim completed primary and secondary schooling in KwaZulu-Natal before pursuing higher education at University of Natal, where she obtained undergraduate and postgraduate degrees. She trained in medicine and epidemiology with mentors connected to World Health Organization, Centers for Disease Control and Prevention, University of London, and University of Cape Town networks, and undertook doctoral studies that engaged with research groups affiliated with National Institutes of Health, Wellcome Trust, and Bill & Melinda Gates Foundation funding streams. Her early career involved placements and collaborations with institutions such as Columbia University, Harvard University, Oxford University, London School of Hygiene & Tropical Medicine, and regional centers like Africa Centre for Health and Population Studies and South African Medical Research Council.

Research and scientific contributions

Abdool Karim's research program has focused on HIV prevention trials, epidemiology of sexually transmitted infections, and implementation science, often in partnership with investigators from National Institutes of Health, Medical Research Council (United Kingdom), Imperial College London, Johns Hopkins University, Karolinska Institute, and McGill University. She has co-led randomized controlled trials testing biomedical interventions such as microbicides and antiretroviral-based prevention developed by teams at Gilead Sciences, Merck & Co., GlaxoSmithKline, CONRAD, and IPM (International Partnership for Microbicides). Her work has integrated virology with social science approaches from collaborators at UNAIDS, UNICEF, PEPFAR, and Global Fund to Fight AIDS, Tuberculosis and Malaria. She contributed to longitudinal cohort studies connecting molecular epidemiology from laboratories at Institut Pasteur, Ragon Institute, and Broad Institute with population-level surveillance carried out by Demographic and Health Surveys teams and UNAIDS epidemiologists. Her scientific publications have informed guidelines from World Health Organization committees, South African National Department of Health, and advisory panels convened by European Medicines Agency, Food and Drug Administration, and UNAIDS.

Public health leadership and policy impact

As a public health leader, Abdool Karim has served on national and international advisory boards and expert panels alongside representatives from United Nations, World Health Organization, National Institutes of Health, Wellcome Trust, and Bill & Melinda Gates Foundation. She has advised ministries and policy bodies including South African National Department of Health, Government of South Africa, and regional bodies such as African Union, Southern African Development Community, and Pan American Health Organization through policy dialogues with stakeholders from Doctors Without Borders, Clinton Health Access Initiative, PATH, and Save the Children. Her guidance influenced implementation of prevention strategies supported by PEPFAR and Global Fund to Fight AIDS, Tuberculosis and Malaria, and she has contributed to capacity building with partners like University of the Witwatersrand, Stellenbosch University, Makerere University, University of Nairobi, and University of Ibadan.

Awards, honors, and recognition

Abdool Karim has received prestigious awards and fellowships from bodies such as Royal Society, The Gairdner Foundation, L'Oréal-UNESCO For Women in Science, MacArthur Foundation, Bill & Melinda Gates Foundation, TWAS (The World Academy of Sciences), and African Academy of Sciences. She has been elected to academies including Academy of Science of South Africa, US National Academy of Medicine, Royal Society of Medicine, and Royal Society of Edinburgh, and recognized by institutions like Harvard University, University of Oxford, Brown University, and University of Cape Town with honorary degrees and distinguished lectureships. Her honors include orders and medals conferred by the Government of South Africa and international prizes awarded by organizations such as Global Health Council, International AIDS Society, and Women in Global Health.

Personal life and advocacy

Abdool Karim is married and balances family life with a career that involves extensive collaboration with individuals and organizations including Desmond Tutu, Nelson Mandela Foundation, Kofi Annan Foundation, and civil society groups like Treatment Action Campaign, SECTION27, and AIDS Healthcare Foundation. She advocates for gender-responsive health policy, youth engagement, and ethical research practices, partnering with advocates from Ann Gloag Foundation, Global Network of People Living with HIV, Frontline AIDS, Equality Now, and Girls Not Brides. Her advocacy work connects to initiatives led by UN Women, Human Rights Watch, Amnesty International, and regional NGOs across Southern Africa, East Africa, and West Africa.

Selected publications and legacy

Abdool Karim's selected publications include influential papers published in journals associated with The Lancet, The New England Journal of Medicine, Nature Medicine, Science Translational Medicine, PLOS Medicine, and BMJ, often co-authored with scientists from Zambia National Public Health Institute, Kenya Medical Research Institute, Botswana Harvard AIDS Institute Partnership, Uganda Virus Research Institute, and Institut Pasteur de Dakar. Her legacy includes mentorship of researchers now at institutions such as Johns Hopkins Bloomberg School of Public Health, Columbia Mailman School of Public Health, Harvard T.H. Chan School of Public Health, University College London, and University of Toronto, and sustained contributions to trial networks like HPTN (HIV Prevention Trials Network), MTN (Microbicide Trials Network), AVAC, and i-Base. She continues to shape scientific agendas through roles on editorial boards of journals like The Lancet HIV, AIDS, and Journal of Infectious Diseases, and through participation in global initiatives led by UNAIDS, WHO, and Global Fund to Fight AIDS, Tuberculosis and Malaria.

Category:South African epidemiologists Category:HIV/AIDS researchers Category:Women in science